Nuvectis Pharma, Inc. Common Stock

NVCT US67080T1088

💰
Capitalization
Small-cap

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

🔗
Website
https://www.nuvectis.com
Annual Performance 1
2022 2023 2024 2025
131% 11% -35% 0%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
42
🙍
Insiders
5
Person Price Shares Total Published Completed
Mosseri Marlio Charles
O 		7.99
USD 		5,603
Bought 		44,768
USD 		20/06/2025 20/06/2025
Mosseri Marlio Charles
O 		7.99
USD 		5,603
Bought 		44,768
USD 		20/06/2025 20/06/2025
Mosseri Marlio Charles
O 		8.05
USD 		28,043
Bought 		225,746
USD 		17/06/2025 18/06/2025
Mosseri Marlio Charles
O 		8.05
USD 		28,043
Bought 		225,746
USD 		17/06/2025 18/06/2025
Mosseri Marlio Charles
O 		8.11
USD 		5,399
Bought 		43,786
USD 		17/06/2025 17/06/2025
Mosseri Marlio Charles
O 		8.11
USD 		5,399
Bought 		43,786
USD 		17/06/2025 17/06/2025
Mosseri Marlio Charles
O 		8.11
USD 		21,167
Bought 		171,664
USD 		12/05/2025 12/05/2025
Mosseri Marlio Charles
O 		8.11
USD 		21,167
Bought 		171,664
USD 		12/05/2025 12/05/2025
Mosseri Marlio Charles
O 		8.90
USD 		9,817
Bought 		87,412
USD 		06/05/2025 09/05/2025
Mosseri Marlio Charles
O 		8.98
USD 		5,395
Bought 		48,426
USD 		06/05/2025 09/05/2025

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Nuvectis Pharma, Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
-20% -22% -41% -70% 0% 0% 66%
Last 52W Low 52W High All-Time Low All-Time High β
6.00 4.52 10.98 3.25 20.44
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Mosseri Marlio Charles 32 2,970,386.22 92,824.57 13/12/2024 20/06/2025
Bentsur Ron 5 196,650.60 39,330.12 18/03/2024 24/12/2024
Poradosu Enrique 3 23,105.00 7,701.67 10/05/2024 19/11/2024
Carson Michael J. 1 22,478.05 22,478.05 07/11/2024 07/11/2024
Shemesh Shay 1 7,034.16 7,034.16 10/05/2024 10/05/2024

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.